Considerations for Hedgehog vs Immunotherapy in Patients with Basal Cell Carcinoma
Experts in dermatology comment on the patient considerations required when deciding on systemic treatment for basal cell carcinoma.
Expert Insights Into Locally Advanced Basal Cell Carcinoma
Drs Sarah Arron and Nathalie Zeitouni share their insights into how they define locally advanced basal cell carcinoma and when they introduce multidisciplinary care.
Management of Newly Diagnosed Patients with Basal Cell Carcinoma (BCC)
Sarah Arron, MD, PhD, and Nathalie Zeitouni, MD, FAAD, discuss their approaches to managing patients with newly diagnosed basal cell carcinoma and highlight the negative consequences of a delayed diagnosis.
Treatment Considerations and Management of Adverse Events when Treating BCC
Experts in dermatology discuss treatment considerations for particular patient populations, highlighting the importance of managing adverse events aggressively.
Efficacy and Safety of Combination Treatments for BCC
Experts in dermatology discuss the efficacy and safety combining hedgehog pathway inhibitors and immunotherapy as treatment for patients with basal cell carcinoma.
Developing a Multidisciplinary Approach when Treating BCC
Todd Schlesinger, MD and Emily Ruiz, MD offer advice on forming multidisciplinary relationships for the wholistic study and treatment of basal cell carcinoma.
Expert Perspectives in Locally Advanced Basal Cell Carcinoma (BCC) Treatment Options
Emily Ruiz, MD and Todd Schlesinger, MD discuss treatment options for locally advanced basal cell carcinoma, such as immunotherapy and surgery.
Key Takeaways and Discussion Highlights
Drs Justine Cohen and Brent Moody provide their key takeaways and panel discussion highlights related to the management of patients with basal cell carcinoma.
Expert Insights into Duration of Treatment for Hedgehog vs Immunotherapy
An expert in dermatology shares her insights into the duration of treatment and dose adjustments for systemic treatments in patients with basal cell carcinoma.
Systemic Treatment Considerations for Basal Cell Carcinoma
Dr Justine Cohen discusses her approach to systemic treatment selection in her patients with basal cell carcinoma; highlighting the importance of individualizing the treatment plan.
Insights into Non-Surgical Approaches to Basal Cell Carcinoma
Justine Cohen, DO and Brent Moody M.D., F.A.C.P., F.A.A.D, comment on which patients would be appropriate for non-surgical treatment options in the management of their basal cell carcinoma.
